AI
Saturday, January 12, 2008 1:08:46 AM
BIIB - Biogen Idec Inc.,
is involved in the development, manufacturing and commercialization of therapies in the areas of oncology, neurology and immunology. The Company has five products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab), ZEVALIN (ibritumomab tiuxetan) and FUMADERM (dimethylfumarate and monoethylfumarate salts).
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
.
.
is involved in the development, manufacturing and commercialization of therapies in the areas of oncology, neurology and immunology. The Company has five products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab), ZEVALIN (ibritumomab tiuxetan) and FUMADERM (dimethylfumarate and monoethylfumarate salts).
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
